Trial intelligence / Profile preview

EPs 7630 film-coated tablets in adults with common cold

2010-022441-21Phase 4Completed

Sponsor
Schwabe Group
Start
Nov 2010
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of pelargonium sidoides extract in nasopharyngitis, sponsored by Schwabe Group. Primary endpoint: Adverse events surveillance. Started Nov 2010; status: completed.

02

Drugs

pelargonium sidoides extract
03

Conditions

nasopharyngitis

Beyond the preview

Go deeper on 2010-022441-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022441-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call